Alcami Capacity Update July 2024: Small Molecule Finished Dosage Form

Alcami is a globally recognized CDMO that partners with clients to bring life-changing medicines to patients. We deliver reliable solutions that unlock the potential of transformative medicines from discovery to commercialization through trusted partnerships with our clients, recognized industry expertise, and a proven regulatory track record. Alcami offers oral solid dose development, solid state characterization, clinical manufacturing, batch scale up, and commercial manufacturing. The OSD facility can handle DEA Schedule I-V material, handling of Safebridge 3b compounds, and Low Humidity Suites qualified to less than 30% RH.

Alcami boasts a state-of-the-art OSD development suite that includes the development version of all of our commercial manufacturing equipment, non-GMP analytical testing lab, stability chambers, and small scale blistering equipment that enables accelerated development of products. The facility can handle commercial blends up to 650Kgs.